SEC Company Response from Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306) (TNXP) — Apr 15, 2020
Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306)
Date: April 15, 2020 · CIK: 0001430306 · Accession: 0001387131-20-003915
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-237610
Letter
Tonix Pharmaceuticals Holding Corp.
Madison Avenue, Suite 1608
New York, New York 10022
April 15, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Tonix Pharmaceuticals Holding Corp.
Registration Statement on Form S-1 (File No. 333-237610)
Filed on April 8, 2020
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Tonix Pharmaceuticals Holding Corp. hereby requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 4:00 p.m., Eastern Time, on April 17, 2020, or as soon as practicable thereafter.
Please call Irina Ishak of Lowenstein Sandler LLP at (973) 422-6406 to confirm the effectiveness of the Registration Statement or with any questions.
[Signature page follows.]
U.S. Securities and Exchange Commission
April 15, 2020
Page
Very truly yours,
TONIX PHARMACEUTICALS HOLDINGS CORP.
Show Raw Text
CORRESP
1
filename1.htm
Tonix
Pharmaceuticals Holding Corp.
509
Madison Avenue, Suite 1608
New
York, New York 10022
April
15, 2020
VIA
EDGAR
United States
Securities and Exchange Commission
Division of
Corporation Finance
100 F Street,
N.E.
Washington,
D.C. 20549
Re: Tonix Pharmaceuticals Holding Corp.
Registration Statement on Form S-1 (File No. 333-237610)
Filed on April 8, 2020
Ladies
and Gentlemen:
In
accordance with Rule 461 under the Securities Act of 1933, as amended, Tonix Pharmaceuticals Holding Corp. hereby requests that
the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities
and Exchange Commission at 4:00 p.m., Eastern Time, on April 17, 2020, or as soon as practicable thereafter.
Please
call Irina Ishak of Lowenstein Sandler LLP at (973) 422-6406 to confirm the effectiveness of the Registration Statement or with
any questions.
[Signature
page follows.]
U.S.
Securities and Exchange Commission
April
15, 2020
Page
2
Very truly yours,
TONIX PHARMACEUTICALS HOLDINGS CORP.
By:
/s/ Bradley Saenger
Name:
Bradley Saenger
Title:
Chief Financial Officer
-2-